[Prenatal diagnosis of cystic fibrosis in risk families in Poland--results of molecular analysis].
BACKGROUND
Cystic fibrosis is one of the most common genetic disorders in the Caucasian population, inherited as an autosomal recessive trait. Diagnosis of CF classifies the patient's family to the group of high genetic risk. In spite of the significant therapeutic advantages this disease is still the cause of preterm death of affected patients. One of the diagnostic tests that are offered to CF risk families is prenatal diagnostics of the disease. This kind of analysis may be performed in the first trimester of pregnancy and is based on the DNA analysis of the foetus.


OBJECTIVE
To sum up and analyse the results of CF prenatal diagnostic studies, in Poland, in the period 1990-2003.


METHODS
In total 45 tests in 38 risk families have been carried out. In case of 7 families in formative results have been obtained due to application of the polymorphic markers analysis. In the remaining cases molecular analysis of foetal DNA focused on identification of specific CFTR gene mutations has been carried out.


RESULTS
In 16 cases the CF genotype was identified. The disease was excluded in 29 foetuses. Some issues of genetic counselling in the context of the possibility of prenatal disease diagnosis have also been discussed.
Bal
Jerzy
J
Zakład Genetyki Medycznej, Instytut Matki i Dziecka, ul. Kasprzaka 17a, 01-211 Warszawa. jbal@imid.med.pl
Sobczyńska-Tomaszewska
Agnieszka
A
Czerska
Kamila
K
Obersztyn
Ewa
E
Sands
Dorota
D
Mazurczak
Tadeusz
T
D003550:Cystic Fibrosis / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000032:analysis; D004247:DNA / Q000032:analysis*; D005260:Female; D006801:Humans; D008297:Male; D011044:Poland / Q000453:epidemiology; D011247:Pregnancy; D011296:Prenatal Diagnosis; D012307:Risk Factors
C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; D004247:DNA